246 related articles for article (PubMed ID: 21765049)
1. Is N-terminal probrain-type natriuretic peptide a clinically useful biomarker of volume overload in peritoneal dialysis patients?
Papakrivopoulou E; Lillywhite S; Davenport A
Nephrol Dial Transplant; 2012 Jan; 27(1):396-401. PubMed ID: 21765049
[TBL] [Abstract][Full Text] [Related]
2. Changes in N-terminal pro-brain natriuretic peptide correlate with fluid volume changes assessed by bioimpedance in peritoneal dialysis patients.
Davenport A
Am J Nephrol; 2012; 36(4):371-6. PubMed ID: 23051933
[TBL] [Abstract][Full Text] [Related]
3. Relations between malnutrition-inflammation-atherosclerosis and volume status. The usefulness of bioimpedance analysis in peritoneal dialysis patients.
Demirci MS; Demirci C; Ozdogan O; Kircelli F; Akcicek F; Basci A; Ok E; Ozkahya M
Nephrol Dial Transplant; 2011 May; 26(5):1708-16. PubMed ID: 20921295
[TBL] [Abstract][Full Text] [Related]
4. Is there a role for N-terminal probrain-type natriuretic peptide in determining volume status in haemodialysis patients?
Kumar S; Khosravi M; Massart A; Davenport A
Nephron Clin Pract; 2012; 122(1-2):33-7. PubMed ID: 23548328
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
[TBL] [Abstract][Full Text] [Related]
6. NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients.
Paniagua R; Ventura MD; Avila-Díaz M; Hinojosa-Heredia H; Méndez-Durán A; Cueto-Manzano A; Cisneros A; Ramos A; Madonia-Juseino C; Belio-Caro F; García-Contreras F; Trinidad-Ramos P; Vázquez R; Ilabaca B; Alcántara G; Amato D
Nephrol Dial Transplant; 2010 Feb; 25(2):551-7. PubMed ID: 19679559
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
[TBL] [Abstract][Full Text] [Related]
8. Association between C-reactive protein levels and N-terminal pro-B-type natriuretic peptide in pre-dialysis patients.
Ortega O; Gallar P; Muñoz M; Rodríguez I; Carreño A; Ortiz M; Molina A; Oliet A; Lozano L; Vigil A
Nephron Clin Pract; 2004; 97(4):c125-30. PubMed ID: 15331941
[TBL] [Abstract][Full Text] [Related]
9. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
Richards M; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton CM; Crozier IG; Yandle TG; Doughty R; MacMahon S; Sharpe N; ;
J Am Coll Cardiol; 2006 Jan; 47(1):52-60. PubMed ID: 16386664
[TBL] [Abstract][Full Text] [Related]
10. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
Wang AY; Lam CW; Yu CM; Wang M; Chan IH; Zhang Y; Lui SF; Sanderson JE
J Am Soc Nephrol; 2007 Jan; 18(1):321-30. PubMed ID: 17167121
[TBL] [Abstract][Full Text] [Related]
11. N-terminal proBNP--marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients?
Booth J; Pinney J; Davenport A
Clin J Am Soc Nephrol; 2010 Jun; 5(6):1036-40. PubMed ID: 20507952
[TBL] [Abstract][Full Text] [Related]
12. N-terminal probrain natriuretic peptide as a predictor of short-term outcomes in acute myocardial infarction.
Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
Indian Heart J; 2005; 57(4):304-10. PubMed ID: 16350675
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of cardiac biomarkers for death in a non-dialysis chronic kidney disease population.
Vickery S; Webb MC; Price CP; John RI; Abbas NA; Lamb EJ
Nephrol Dial Transplant; 2008 Nov; 23(11):3546-53. PubMed ID: 18562472
[TBL] [Abstract][Full Text] [Related]
14. Inflammation, overhydration and cardiac biomarkers in haemodialysis patients: a longitudinal study.
Jacobs LH; van de Kerkhof JJ; Mingels AM; Passos VL; Kleijnen VW; Mazairac AH; van der Sande FM; Wodzig WK; Konings CJ; Leunissen KM; van Dieijen-Visser MP; Kooman JP
Nephrol Dial Transplant; 2010 Jan; 25(1):243-8. PubMed ID: 19692417
[TBL] [Abstract][Full Text] [Related]
15. Predialysis NTproBNP predicts magnitude of extracellular volume overload in haemodialysis patients.
Nongnuch A; Panorchan K; Davenport A
Am J Nephrol; 2014; 40(3):251-7. PubMed ID: 25322897
[TBL] [Abstract][Full Text] [Related]
16. Fluid overload correction and cardiac history influence brain natriuretic peptide evolution in incident haemodialysis patients.
Chazot C; Vo-Van C; Zaoui E; Vanel T; Hurot JM; Lorriaux C; Mayor B; Deleaval P; Jean G
Nephrol Dial Transplant; 2011 Aug; 26(8):2630-4. PubMed ID: 21273234
[TBL] [Abstract][Full Text] [Related]
17. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
[TBL] [Abstract][Full Text] [Related]
18. Aminoterminal B-type natriuretic peptide (NT-proBNP) in end-stage renal failure patients on regular hemodialysis: does it have diagnostic and prognostic implications?
Pimenta J; Sampaio F; Martins P; Carvalho B; Rocha-Gonçalves F; Ferreira A; Bettencourt P
Nephron Clin Pract; 2009; 111(3):c182-8. PubMed ID: 19194108
[TBL] [Abstract][Full Text] [Related]
19. Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients.
Hickman PE; McGill DA; Talaulikar G; Hiremagalur B; Bromley J; Rahman A; Koerbin G; Southcott E; Potter JM
Intern Med J; 2009 Dec; 39(12):812-8. PubMed ID: 20233242
[TBL] [Abstract][Full Text] [Related]
20. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
